These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 15256187

  • 1. Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
    Morris GL, Hammer AE, Kustra RP, Messenheimer JA.
    Epilepsy Behav; 2004 Aug; 5(4):509-12. PubMed ID: 15256187
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
    Machado RA, García VF, Astencio AG, Cuartas VB.
    Seizure; 2013 Dec; 22(10):846-55. PubMed ID: 23916525
    [Abstract] [Full Text] [Related]

  • 3. A dosing algorithm for converting from valproate monotherapy to lamotrigine monotherapy in patients with epilepsy.
    Sale ME, Natarajan S, Biton V, Vuong A, Hammer AE, Messenheimer JA, Blum D.
    Epilepsy Behav; 2005 Feb; 6(1):63-70. PubMed ID: 15652736
    [Abstract] [Full Text] [Related]

  • 4. The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
    Montouris G, Abou-Khalil B.
    Epilepsia; 2009 Sep; 50 Suppl 8():16-20. PubMed ID: 19702728
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA, Hammer AE, Vuong A, Messenheimer JA.
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
    Kothare SV, Valencia I, Khurana DS, Hardison H, Melvin JJ, Legido A.
    Epileptic Disord; 2004 Dec; 6(4):267-70. PubMed ID: 15634623
    [Abstract] [Full Text] [Related]

  • 8. [Juvenile myoclonic epilepsy with recurrent myoclonic status: efficacy of valproate].
    Crespel A, Velizarova R, Genton P, Gélisse P.
    Therapie; 2009 Dec; 64(5):321-3. PubMed ID: 19863907
    [Abstract] [Full Text] [Related]

  • 9. Evolving antiepileptic drug treatment in juvenile myoclonic epilepsy.
    Prasad A, Kuzniecky RI, Knowlton RC, Welty TE, Martin RC, Mendez M, Faught RE.
    Arch Neurol; 2003 Aug; 60(8):1100-5. PubMed ID: 12925366
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine].
    Maiga Y, Nogues B, Guillon B.
    Rev Neurol (Paris); 2006 Nov; 162(11):1125-7. PubMed ID: 17086150
    [Abstract] [Full Text] [Related]

  • 15. Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
    Chowdhury A, Brodie MJ.
    Epilepsy Res; 2016 Jan; 119():62-6. PubMed ID: 26675554
    [Abstract] [Full Text] [Related]

  • 16. Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
    Milano C, Turco F, Pizzanelli C, Bonanni E, Siciliano G, Fornai F, Giorgi FS.
    Epilepsy Behav; 2021 Feb; 115():107706. PubMed ID: 33423017
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Outcome of lamotrigine treatment in juvenile myoclonic epilepsy.
    Bodenstein-Sachar H, Gandelman-Marton R, Ben-Zeev B, Chapman J, Blatt I.
    Acta Neurol Scand; 2011 Jul; 124(1):22-7. PubMed ID: 21208196
    [Abstract] [Full Text] [Related]

  • 20. A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy.
    Park KM, Kim SH, Nho SK, Shin KJ, Park J, Ha SY, Kim SE.
    J Clin Neurosci; 2013 Aug; 20(8):1079-82. PubMed ID: 23673144
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.